CALABRESI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 689
NA - Nord America 689
AS - Asia 125
AF - Africa 3
OC - Oceania 1
SA - Sud America 1
Totale 1.508
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 688
PL - Polonia 220
RU - Federazione Russa 216
IT - Italia 100
IE - Irlanda 44
SG - Singapore 41
SE - Svezia 35
CH - Svizzera 30
CN - Cina 29
HK - Hong Kong 26
DE - Germania 13
GB - Regno Unito 11
JO - Giordania 11
IN - India 8
FR - Francia 6
VN - Vietnam 6
FI - Finlandia 5
BE - Belgio 4
KR - Corea 4
CI - Costa d'Avorio 2
ES - Italia 2
NL - Olanda 2
AU - Australia 1
BR - Brasile 1
CA - Canada 1
MU - Mauritius 1
UA - Ucraina 1
Totale 1.508
Salva come PNG Salva come JPEG
Città #
Warsaw 220
Santa Clara 143
Fairfield 73
Chandler 52
Dublin 44
Ashburn 39
Florence 37
Woodbridge 37
Seattle 35
Houston 33
Ann Arbor 30
Cambridge 30
Singapore 29
Bern 28
Wilmington 24
Hong Kong 18
Altamura 14
Lawrence 14
Princeton 11
Beijing 10
Bremen 10
Buffalo 9
Moscow 9
Boston 8
Los Angeles 8
Mumbai 7
Dong Ket 6
Kent 6
New York 6
Dearborn 5
Brussels 4
Cagliari 4
San Diego 4
Seoul 4
Boardman 3
Hillsboro 3
Redwood City 3
San Jose 3
Shanghai 3
Yubileyny 3
Abidjan 2
Basel 2
Cantagallo 2
Cusano Milanino 2
Ealing 2
Falls Church 2
Fiesole 2
Kunming 2
Medford 2
Phoenix 2
Reston 2
Romainville 2
Seville 2
Andover 1
Augusta 1
Bethesda 1
Corato 1
Falkenstein 1
Fiumicino 1
Fontebuona 1
Hangzhou 1
Helsinki 1
Jacksonville 1
Lappeenranta 1
Livorno 1
Milan 1
Monteroni D'arbia 1
Montreal 1
Munich 1
Nanchang 1
Noisy-le-sec 1
Perth 1
Pisa 1
Pune 1
Rome 1
Salerno 1
Scarperia e San Piero 1
Schiavon 1
Shenzhen 1
Signa 1
São Paulo 1
Tappahannock 1
Wandsworth 1
Xian 1
Xuzhou 1
Zhoukou 1
Totale 1.088
Salva come PNG Salva come JPEG
Nome #
Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis 263
Inhibitors of the PI3K/mTOR pathway prevent STAT5 phosphorylation in JAK2V617F mutated cells through PP2A/ CIP2A axis 178
Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants 173
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: Pathogenetic insight and diagnostic value 133
Characterization of novel molecular targets and mechanisms in Philadelphia-negative Myeloproliferative Neoplasms 132
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value. 117
CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles 112
Extramedullary blastic transformation of primary myelofibrosis in the form of disseminated myeloid sarcoma: a case report and review of the literature 105
Activated IL-6 signaling contributes to the pathogenesis of, and is a novel therapeutic target for, CALR-mutated MPNs 77
Molecular Characterization of Response/Loss-of-Response to Ruxolitinib in Patients with Myelofibrosis 60
The MPL mutation 57
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model 46
Clonal dynamics and copy number variants by single-cell analysis in leukemic evolution of myeloproliferative neoplasms 38
Immunoblotting-assisted assessment of JAK/STAT and PI3K/Akt/mTOR signaling in myeloproliferative neoplasms CD34+ stem cells 26
Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes 14
Totale 1.531
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.696
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.696
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020196 0 0 0 0 29 37 25 39 23 13 25 5
2020/2021156 9 23 4 20 11 16 8 10 15 23 7 10
2021/202270 1 2 8 0 2 4 0 7 5 6 14 21
2022/2023268 15 51 14 22 15 34 30 14 29 2 9 33
2023/2024132 2 15 15 5 12 16 1 37 4 5 13 7
2024/2025458 27 72 44 131 184 0 0 0 0 0 0 0
Totale 1.531